Tempus AI Revenue 2023-2025 | TEM
Tempus AI annual/quarterly revenue history and growth rate from 2023 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Tempus AI revenue for the quarter ending March 31, 2025 was $0.256B, a 75.38% increase year-over-year.
- Tempus AI revenue for the twelve months ending March 31, 2025 was $0.803B, a 42.93% increase year-over-year.
- Tempus AI annual revenue for 2024 was $0.693B, a 30.38% increase from 2023.
- Tempus AI annual revenue for 2023 was $0.532B, a 65.85% increase from 2022.
- Tempus AI annual revenue for 2022 was $0.321B, a 0% decline from .
| Tempus AI Annual Revenue (Millions of US $) |
|
|---|---|
| 2024 | $693 |
| 2023 | $532 |
| 2022 | $321 |
| Tempus AI Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2025-03-31 | $256 |
| 2024-12-31 | $201 |
| 2024-09-30 | $181 |
| 2024-06-30 | $166 |
| 2024-03-31 | $146 |
| 2023-12-31 | $148 |
| 2023-09-30 | $136 |
| 2023-06-30 | $132 |
| 2023-03-31 | $116 |
| 2022-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $12.011B | $0.693B |
| Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $46.227B | 59.07 |
| Hims & Hers Health (HIMS) | United States | $12.367B | 128.49 |
| IRhythm Technologies (IRTC) | United States | $4.742B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $4.033B | 63.01 |
| Hinge Health (HNGE) | United States | $2.855B | 0.00 |
| Privia Health (PRVA) | United States | $2.804B | 191.67 |
| Schrodinger (SDGR) | United States | $1.917B | 0.00 |
| Enovis (ENOV) | United States | $1.916B | 10.69 |
| Phreesia (PHR) | United States | $1.667B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.522B | 0.00 |
| Omnicell (OMCL) | United States | $1.463B | 25.82 |
| Azenta (AZTA) | United States | $1.393B | 64.72 |
| 10x Genomics (TXG) | United States | $1.311B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.663B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.645B | 0.00 |
| Claritev (CTEV) | United States | $0.631B | 0.00 |
| Talkspace (TALK) | United States | $0.499B | 149.00 |
| Veradigm (MDRX) | United States | $0.476B | 0.00 |
| Standard BioTools (LAB) | United States | $0.410B | 0.00 |
| TruBridge (TBRG) | United States | $0.372B | 824.33 |
| Outset Medical (OM) | United States | $0.366B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.288B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.266B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.199B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.148B | 0.00 |
| Pulmonx (LUNG) | United States | $0.137B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.124B | 0.00 |
| American Well (AMWL) | United States | $0.115B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.102B | 0.00 |
| CareCloud (CCLD) | United States | $0.094B | 3.60 |
| 111 (YI) | China | $0.070B | 0.00 |
| HeartBeam (BEAT) | United States | $0.054B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.046B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.035B | 0.00 |
| Zhongchao (ZCMD) | China | $0.034B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.030B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.022B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.018B | 0.00 |
| Precipio (PRPO) | United States | $0.017B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.012B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.009B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.000B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |